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Abstract
After percutaneous transluminal coronary angioplasty (PTCA), stress-echocardiography and gated
single photon emission computerized tomography (g-SPECT) are usually performed but both tools
have technical limitations. The present study evaluated results of PTCA of left anterior descending
artery (LAD) six months after PTCA, by combining transthoracic Doppler coronary flow reserve
(CFR) and color Tissue Doppler (C-TD) dobutamine stress.
Six months after PTCA of LAD, 24 men, free of angiographic evidence of restenosis, underwent
standard Doppler-echocardiography, transthoracic CFR of distal LAD (hyperemic to basal diastolic
coronary flow ratio) and C-TD at rest and during dobutamine stress to quantify myocardial systolic
(Sm) and diastolic (Em and Am, Em/Am ratio) peak velocities in middle posterior septum. Patients with
myocardial infarction, coronary stenosis of non-LAD territory and heart failure were excluded.
According to dipyridamole g-SPECT, 13 patients had normal perfusion and 11 with perfusion
defects. The 2 groups were comparable for age, wall motion score index (WMSI) and C-TD at rest.
However, patients with perfusion defects had lower CFR (2.11 ± 0.4 versus 2.87 ± 0.6, p < 0.002)
and septal Sm at high-dose dobutamine (p < 0.01), with higher WMSI (p < 0.05) and stress-echo
positivity of LAD territory in 5/11 patients. In the overall population, CFR was related negatively
to high-dobutamine WMSI (r = -0.50, p < 0.01) and positively to high-dobutamine Sm of middle
septum (r = 0.55, p < 0.005).
In conclusion, even in absence of epicardial coronary restenosis, stress perfusion imaging reflects a
physiologic impairment in coronary microcirculation function whose magnitude is associated with
the degree of regional functional impairment detectable by C-TD.
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Introduction
Percutaneous transluminal coronary angioplasty (PTCA)
has deeply modified the effective management of coro-
nary artery disease [1]. Coronary artery restenosis is unfre-
quent when PTCA is associated to coronary stenting
application which is able to enlarge the lumen area steno-
sis [2,3]. However, even in absence of coronary artery res-
tenosis, the results of revascularization can be suboptimal
because of coronary microvessel dysfunction subsequent
to the procedure [4,5]. This issue may be intriguing for
management of patients undergone PTCA.
The non-invasive assessment after PTCA is usually per-
formed by gated single photon emission computerized
tomography (g-SPECT) [6,7] and by stress echocardiogra-
phy [7,8]. However, both these tools present technical
limitations, g-SPECT having a low specificity [9] and
semi-quantitative echocardiographic wall motion analysis
low sensitivity [10].
In the last years, great interest has been developed about
new echocardiographic techniques as Doppler-derived
coronary flow reserve (CFR) [11,12] and color Tissue
Doppler (C-TD) [13,14]. The first tool provides reliable
information about coronary microvascular function in
absence of epicardial coronary stenosis [15] while C-TD is
able to quantify left ventricular (LV) myocardial perform-
ance both at rest and during pharmacological stress
[13,14].
On these grounds, aim of the present study was to assess
C-TD derived myocardial performance, both at rest and
during pharmacologic stress, in relation to the function of
coronary microcirculation determined by non invasive
CFR after successful PTCA of LAD.
Methods
Study population
Among 30 patients who had undergone PTCA with stent-
ing for significant LAD stenosis between September and
October 2000, 24 patients (age = 50–64 years) free of cor-
onary angiographic evidence of LAD restenosis 6 months
after the procedure, entered the study and performed non-
invasive test screening in the same period of the invasive
assessment (±7 days). The informed consent of all
patients and approval of Institutional Committee were
obtained. Patients were excluded for acute and previous
myocardial infarction (according to ECG at rest), concom-
itant coronary stenosis of right coronary artery and/or cir-
cumflex artery, congestive heart failure, valvular heart
disease, primary cardiomyopathy, atrial fibrillation, inad-
equate quality echocardiograms. On the basis of g-SPECT
dipyridamole induced perfusion defects, the study popu-
lation was divided into 2 groups: without and with per-
fusion defects.
Procedures
Patients underwent dipyridamole gated myocardial per-
fusion g-SPECT acquisition, transthoracic echocardiogra-
phy, C-TD (both at baseline and during dobutamine
stress) and non-invasive CFR determination by dipyrida-
mole test. All echocardiographic measurements were ana-
lyzed without knowledge of the clinical data. According to
the rules of the Institutional Committees, all patients
withdrew cardiac drugs at least 2 days before the perform-
ance of the non invasive assessment.
Dipyridamole g-SPECT
Single day rest/dipyridamole g-SPECT was performed
according to the standard methods by injecting patients
with technetium 99m (99mTc) tetrophosmin 8 mCi (296
MBq) at rest and 24 mCi (888 MBq) after dipyridamole
infusion by volumetric pump (dose of 0.14 mg/kg/min in
4 minutes) [16,17]. A single stress SPECT corresponds to
a dose exposure of about 500 chest x-ray. Qualitative
assessment of reconstructed gated images was obtained
on mid-short axis slices, vertical and horizontal long axis
slices.
Transthoracic Echocardiography
Standard echocardiographic examinations were per-
formed using a System FiVe, Vingmed Sound AB machine
(GE, Horten, Norway), by a 2.5 MHz transducer equipped
with second harmonic capability. M-mode echocardio-
graphic analysis was performed according to the criteria of
the American Society of Echocardiography [18] and LV
mass indexed for height powered to 2.5 [19]. LV end-
diastolic and end-systolic volumes were estimated accord-
ing to the Simpson method [20] and LV ejection fraction
derived.
Stress protocols
Dobutamine stress protocol was performed according to
the standard method [21] using low and high-dose (up to
40  µg/Kg/min) by using the System FiVe Vingmed
machine. C-TD of posterior septum was recorded at rest
and during each dobutamine stage. CFR assessment was
performed by HDI 5000 ultrasound machine (ATL Ultra-
sound, Bothell, Washington, USA), using a high-fre-
quency (7 MHz) transducer. The visualization of the distal
portion of the left anterior descending artery and the
recording of PW-Doppler derived coronary blood flow
velocities performed at baseline and after dipyridamole
infusion (0.56 mg/kg over 4 minutes) according to the
standards of our laboratory [14]. Blood pressure and a 12-
lead ECG were recorded at rest and at the end of each stage
of both dobutamine and dipyridamole tests.
C-TD dobutamine stress echocardiography analysis
Echocardiographic images were recorded on S-VHS video-
tapes and digitally stored on magneto-optical disk forCardiovascular Ultrasound 2004, 2:26 http://www.cardiovascularultrasound.com/content/2/1/26
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subsequent analysis. Images were evaluated by 2 experi-
enced observers. Baseline and stress wall motion analysis
was performed by 2 experienced readers blinded to the
other data. Regional wall motion was assessed with a 16-
segment model of the left ventricle and semiquantitatively
graded from 1 to 4 as follows: 1 = normal; 2 = hypoki-
nesia; 3 = akinesia; and 4 = dyskinesia. A wall motion
score index (WMSI), obtained dividing the sum of each
segment scores by the number of the segments, was
assessed both at baseline and at high-dose dobutamine.
C-TD acquisition of posterior septal wall was performed
in real time, superimposed on 2-D images, at baseline and
at the end of each dobutamine infusion stage. C-TD imag-
ing was stored in digital format and analyzed off line on
cine-loop as previously described [14]. The region of
interest was the middle segment of the posterior septum
where myocardial velocity profile was obtained. The mid-
dle posterior septum for measurements of C-TD was cho-
sen since the perfusion of this myocardial segment is
provided by a branch of LAD, where also CFR was deter-
mined. The reproducibility of C-TD of our laboratory has
been reported, the intra- and inter-observer variability
being <3% and <6% for all the measurements both at rest
and at high-dose dobutamine [22].
CFR Analysis
Methods and reproducibility (intra-observer and inter-
observer variability 1.9% and 4.2% respectively) of our
laboratory in measuring coronary blood flow reserve has
been described [22]. By placing sample volume on the
color signal, spectral Doppler of LAD flow showed the
characteristic biphasic flow pattern with a larger diastolic
and a smaller systolic component. Diastolic peak veloci-
ties were measured at baseline and after dipyridamole, by
averaging the highest 3 spectral Doppler signals for each
measurement. CFR was defined as the ratio of hyperemic
to basal diastolic peak velocities. All images were recorded
on a magneto-optical disk and analyzed off-line by 2 inde-
pendent observers, blinded to the other data.
Statistical Analysis
The analyses were performed by SPSS for Windows release
8.0 (Chicago, Illinois, USA). Data are presented as mean
value ± SD. Analysis of variance was used to assess inter-
group differences. Linear regression analyses and partial
correlation test was done using Pearson's method. Differ-
ences were considered significant at p < 0.05.
Results
Characteristics of the study population
The characteristics of the study population and both heart
rate and blood pressure at baseline and at high-dose dob-
utamine are listed in Table 1. The 2 groups were compara-
ble for heart rate and blood pressure values both at rest
and at stress dobutamine peak. Of note, the prevalence of
arterial hypertension, diabetes mellitus, hypercholestero-
lemia and smoke was not different between groups and
no patients of both groups presented g-SPECT derived
myocardial perfusion defects at rest (data not reported in
Table).
Echocardiographic analysis
The comparisons of echocardiographic measurements
and CFR between the 2 groups are reported in Table 2.
Because of higher septal and posterior wall thickness,
patients with myocardial perfusion defects after PTCA had
greater LV mass index (p < 0.05). LV ejection fraction was
comparable between the 2 groups.
Dobutamine test and Color TD analysis
WMSI was comparable between the 2 groups at baseline
(1.07 ± 0.10 versus 1.15 ± 0.11) whereas it was higher at
low-dose dobutamine (1.07 ± 0.11 versus 1.17 ± 0.12)
and at high-dose dobutamine (1.07 ± 0.12 versus 1.20 ±
0.14) (both p < 0.05) in patients with SPECT-derived per-
fusion defects than in controls. Positive dobutamine
Table 1: Characteristics of the study population
Variable Normal Perfusion n = 13 Perfusion Defect n = 11 P
Age (years) 55.9 ± 4.1 58.4 ± 3.1 NS
Body mass index (Kg/m2) 26.1 ± 1.1 26.3 ± 0.8 NS
Baseline Systolic BP (mm Hg) 147.0 ± 7.5 149.2 ± 11.6 NS
Baseline Diastolic BP (mm Hg) 85.1 ± 7.5 85.5 ± 9.1 NS
Baseline Heart rate (bpm) 74.8 ± 5.9 73.7 ± 6.9 NS
DOB Systolic BP (mm Hg) 151.1 ± 7.5 151.9 ± 10.2 NS
DOB Diastolic BP (mm Hg) 83.2 ± 6.3 83.4 ± 7.3 NS
DOB Heart rate (bpm) 139.6 ± 5.4 141.0 ± 5.5 NS
BP = Blood Pressure, DOB = DobutamineCardiovascular Ultrasound 2004, 2:26 http://www.cardiovascularultrasound.com/content/2/1/26
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Table 2: Standard Doppler echocardiographic and CFR analysis
Variable Normal Perfusion Perfusion Defect P
Septal wall thickness (mm) 10.1 ± 1.4 11.2 ± 0.4 <0.02
Posterior wall thickness (mm) 10.2 ± 1.4 10.6 ± 0.5 NS
LV internal diastolic diameter (mm) 54.7 ± 2.6 56.7 ± 3.5 NS
LV internal systolic diameter (mm) 39.2 ± 2.8 39.6 ± 2.9 NS
2-D Ejection Fraction (%) 54.8 ± 6.0 54.9 ± 3.4 NS
LV mass index (g/m 2.7) 49.6 ± 10.7 57.9 ± 8.0 <0.05
LV = left ventricular
In the left panel comparison of Sm peak velocity of middle posterior septum of patients without and with SPECT perfusion  defects at rest, at low and at high-dose dobutamine Figure 1
In the left panel comparison of Sm peak velocity of middle posterior septum of patients without and with SPECT perfusion 
defects at rest, at low and at high-dose dobutamine. In the right panel comparison of Sm peak velocity of middle posterior sep-
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stress-echo involving LAD territory (and in particular mid-
septal region) was observed in 5/11 patients (45.4%) with
SPECT perfusion defects.
C-TD diastolic measurements of mid-septum (Em, Am, Em/
Am ratio) were similar between the two groups at rest (Em/
Am ratio = 1.04 ± 0.1 and 1.03 ± 0.3 in patients with and
without perfusion defects respectively, NS) and at low
dose dobutamine (Em/Am ratio = 1.00 ± 0.1 and 1.13 ± 0.4
respectively, NS) while Em/Am ratio was mildly different at
high-dose dobutamine (0.83 ± 0.2 and 0.70 ± 0.2 respec-
tively, p < 0.05). Sm peak velocities were lower in patients
with perfusion defects at low- (p < 0.05) and at high-dose
dobutamine (p < 0.01) and were significantly lower also
in patients with perfusion defects showing stress induced
wall motion abnormalities in comparison with patients
with perfusion defects but no change of wall motion dur-
ing dobutamine infusion (Figure 1).
CFR analysis
Coronary diastolic peak velocities were similar at rest
between the two groups (21.5 ± 5.2 cm/s in patients with-
out perfusion defects and 22.0 ± 19 cm/s in patients with
perfusion defects, NS) but significantly different after
dipyridamole (60.0 ± 16.1 cm/s versus 49.1 ± 10.8 cm/s
respectively, p < 0.05). Thus, CFR was 2.87 ± 0.6 in
patients without defects and 2.11 ± 0.4 in patients with
perfusion defects (p < 0.002). Of note, analyzing the
group with SPECT-derived perfusion defects, the patients
with stress inducible wall motion abnormalities had
lower CFR (1.91 ± 0.1) than those without change of
WMSI during dobutamine infusion (2.28 ± 0.4) (p =
0.06).
Relationship between CFR and Dobutamine stress measurements
In the overall population, CFR was negatively related to
WMSI at low-dose (r = -0.46, p < 0.02) and high-dose dob-
utamine (r = -0.50, p < 0.01). Among C-TD Doppler meas-
urements, CFR was positively related to Sm peak velocity
of middle septum at low dose (r = 0.39, p < 0.05) and
high-dose dobutamine (r = 0.55, p < 0.0005) (Figure 2)
while the relation of Sm at baseline (r = 0.12) did not
achieve the statistical significance. No relation of CFR was
found with C-TD diastolic measurements of middle sep-
tum at any stage of dobutamine stress. Figure 3 shows a
patient with SPECT derived normal perfusion: CFR is >2
and middle septal Sm peak velocity has a significant incre-
ment from baseline to high-dose dobutamine (∆ = +9).
Figure 4 displays a patient with a perfusion defect: CFR is
reduced and middle septal Sm increase from baseline to
high-dose dobutamine is lower (∆ = +5).
Discussion
The present study used new ultrasound tools, as off-line
quantitative C-TD [13,14] and Doppler-derived CFR [15],
to evaluate long-term effects of PTCA on the relation
between myocardial performance and coronary microvas-
cular function, in the absence of angiographic coronary
artery restenosis. According to dipyridamole g-SPECT, the
population was divided into 2 groups, the first without
and the second one with perfusion defect in the LAD ter-
ritory, comparable for resting LV ejection fraction. Our
findings show that, six months after successful PTCA of
LAD, patients with myocardial perfusion defects present
both lower CFR and reduced peak dobutamine myocar-
dial systolic function of wall involved by LAD perfusion
(i.e., middle posterior septum) in comparison with the
control group and that CFR is positively related to stress
peak Sm velocity measured at middle septum in the overall
population.
CFR and perfusion defect after PTCA
According to the study design, we intentionally selected
patients without angiographic evidence of post-PTCA
LAD restenosis. Worthy of note, the incidence of coronary
restenosis was very low 6 months after the procedure, in
accord with previous experiences about the combined use
of stenting and PTCA [23]. Nevertheless, 11 our patients
without restenosis showed dipyridamole g-SPECT LAD
perfusion defects. Myocardial hypoperfusion may occur
in patients without overt epicardial coronary artery steno-
sis having coronary microvessel damage [24,25] and
coronary microvascular dysfunction corresponds to a
reduced CFR in the absence of epicardial coronary steno-
sis [26]. Accordingly, the patients of the present study
Positive association between CFR and C-TD derived Sm peak  velocity of middle septum at high-dose dobutamine Figure 2
Positive association between CFR and C-TD derived Sm peak 
velocity of middle septum at high-dose dobutamine. Full cir-
cles indicate patients with SPECT-derived myocardial per-
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with long-standing SPECT perfusion defects showed
lower CFR than the control group. An abnormal CFR had
been already described immediately after balloon angi-
oplasty [5,27,28], probably because of a slow recovery of
autoregulation in the microvascular bed [29]. This reduc-
tion is primarily due to an increased flow velocity at rest
[5,27,28], in relation to the failure of microvessel bed to
vasoconstrict appropriately and/or to epicardial vasocon-
striction mediated by a myogenic response and/or neural
mechanism [30]. In contrast to previous studies showing
normalization of CFR after three [31], five [32] or six
months [5], CFR was persistently reduced in our patients
with SPECT-derived perfusion defects. A suboptimal Dop-
pler flow wire derived CFR had been observed six months
after PTCA without restenosis by DEBATE investigators
[33]. In the suboptimal CFR group the reduction of CFR
was mainly due to a long-standing elevation in resting
peak velocities while in our patients with perfusion
defects it was due to a blunted maximal vasodilator
response to dypiridamole. It is conceivable that this alter-
ation could depend on endothelial damage of coronary
microcirculation [34] preceding the procedure and per-
sisting long time after PTCA. Coronary microcirculatory
vasoconstriction induced by endothelial dysfunction has
been described as effect of spontaneous myocardial
ischemia [35] as well as in conditions other than epicar-
dial coronary artery stenosis, as diabetes mellitus [36,37]
arterial hypertension [26,38] and LV hypertrophy [39,40],
which can alter microvascular function. However, an
alternative interpretation of our findings include the pos-
CFR and Sm peak velocity of middle septum at high-dose dobutamine in a patient with SPECT derived normal perfusion Figure 3
CFR and Sm peak velocity of middle septum at high-dose dobutamine in a patient with SPECT derived normal perfusion. The 
upper panels show coronary artery flow velocity in the LAD at baseline and with a normal increase with dipyridamole (DIP). In 
the lower panels, myocardial systolic velocity (Sm) shows a normal increase at high-dose dobutamine.Cardiovascular Ultrasound 2004, 2:26 http://www.cardiovascularultrasound.com/content/2/1/26
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sibility that a residual coronary stenosis might be anatom-
ically insignificant but hemodynamically important, thus
explaining a discrepancy between the percentage of lumen
reduction and the amount of regional flow reserve.
Myocardial systolic function and perfusion defect after 
PTCA
The reduction of myocardial systolic function expressed
by the decrease of low and high-dose dobutamine Sm in
middle septum, i.e. in the territory supplied by LAD, is not
surprising in patients with perfusion defects after PTCA.
Of note, myocardial systolic performance of middle sep-
tum was not significantly different between the 2 groups
at rest. These findings are consistent with an altered myo-
cardial systolic velocity response to exercise already
described by C-DT in patients with coronary artery disease
[13,41]. Also WMSI, not different at rest, became signifi-
cantly higher at low and high-dose dobutamine in
patients with perfusion defects. This increase (involving
LV segments of LAD territory) during stress occurred only
in 5/11 patients who had lower Sm peak velocities at peak
dobutamine stress and lower CFR than patients without
inducible wall motion abnormalities. Myocardial reper-
fusion injury may include LV regional systolic dysfunction
as irreversible manifestation, it depending by a reduction
of myocardial blood flow reserve [5]. Inducible wall
motion abnormalities in the presence of a successful
CFR and septal Sm peak velocity at high-dose dobutamine in a patient with SPECT derived perfusion defect Figure 4
CFR and septal Sm peak velocity at high-dose dobutamine in a patient with SPECT derived perfusion defect. The upper panels 
display a reduced CFR. In the lower panels, the increase of septal Sm from baseline to high-dose dobutamine is low.Cardiovascular Ultrasound 2004, 2:26 http://www.cardiovascularultrasound.com/content/2/1/26
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coronary revascularization might indicate a very severe
microvascular damage.
Association between CFR and myocardial systolic function
It is recognized that the extent of stress dobutamine-
induced dissinergy is associated to the degree of CFR
reduction in patients with significant coronary artery ste-
nosis, an invasive myocardial fractional flow reserve
≤0.75 having a sensitivity of 76% and a specificity of 97%
[42]. In agreement with these findings, we found a posi-
tive association between the functional degree of vasodi-
lator microvascular coronary circulation and the
magnitude of regional myocardial systolic function at
peak dobutamine stress, i.e. Sm peak velocity of the wall
(middle septum) supplied by LAD. Accordingly, we also
found a lower but significant negative relation between
CFR and stress peak WMSI. Since patients undergoing suc-
cessful reperfusion procedures generally present a good
stress-echo LV functional response [6], our data suggest
the ability of C-DT to detect even minor forms of LV
regional myocardial dysfunction occurring under these
circumstances.
Study Limitations
The main limitation of the present study include the fact
that the negativity of coronary angiography can not
exclude definitely the presence of coronary restenosis
while an invasive measurement of CFR by Doppler flow
wire or an intra-coronary ultrasound could have been
crucial to clarify this issue. Unfortunately, these evalua-
tions were not included into our study protocol. In addi-
tion, it has also to be underscored that patients with
perfusion defects of the present study had greater LV mass,
a factor which can itself induce a reduction of CFR
[39,40].
Clinical implications
The results of the present study suggest that CFR impair-
ment may be detectable after PTCA even in the absence of
coronary restenosis, it depending by an altered coronary
microvascular function. In this clinical scenario, SPECT
stress perfusion defects have to be interpreted as false pos-
itive results for PCTA restenosis while they reflect a true
physiologic impairment in regional CFR with some asso-
ciated degree of systolic impairment detectable by C-TD.
Quantitative parameters of CFR and C-TD can provide an
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